REPLIGEN CORP Insider Trading Activity

Q: What insider transaction did Repligen (RGEN) disclose in this Form 4?

The filing reports that a director of Repligen sold 275 shares of Repligen common stock on 12/17/2025 at a price of $161 per share.

Q: What is the relationship of the reporting person to Repligen (RGEN)?

The reporting person is identified as a director of Repligen Corp, with the director box checked in the relationship section.

Q: Was this Repligen (RGEN) Form 4 filed for one person or a group?

The document indicates that it is a Form 4 filed by one reporting person, not by a group of insiders.

Q: What type of Repligen (RGEN) securities are involved in this Form 4?

The transaction involves Repligen common stock listed in Table I. Table II for derivative securities does not show any derivative transactions in the provided excerpt.

Q: When was the earliest transaction date reported in this Repligen (RGEN) Form 4?

The earliest transaction date disclosed is 12/17/2025, which matches the date of the sale of 275 shares of common stock.

A director of Repligen Corp (RGEN) reported a small open-market sale of company stock.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

A director of Repligen Corp (RGEN) reported a small open-market sale of company stock. On 12/17/2025, the director sold 275 shares of Repligen common stock at a price of $161 per share, as shown in Table I of the filing. After this transaction, the director continued to beneficially own 91,821 shares of Repligen common stock, held as a direct ownership position. The report was filed as a Form 4 for one reporting person, indicating routine insider transaction disclosure.

Insider Trade Summary

Net Seller: 275 shares

Net Sell 1 txn

Insider DAWES KAREN A

Role Director

Sold 275 shs ($44K)

Type	Security	Shares	Price	Value
Sale	Common Stock	275	$161.00	$44K

Holdings After Transaction: Common Stock — 91,821 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Repligen (RGEN) disclose in this Form 4?

The filing reports that a director of Repligen sold 275 shares of Repligen common stock on 12/17/2025 at a price of $161 per share.

How many Repligen (RGEN) shares does the reporting person own after the transaction?

Following the reported sale, the director beneficially owned 91,821 shares of Repligen common stock, held as a direct ownership position.

What is the relationship of the reporting person to Repligen (RGEN)?

The reporting person is identified as a director of Repligen Corp, with the director box checked in the relationship section.

Was this Repligen (RGEN) Form 4 filed for one person or a group?

The document indicates that it is a Form 4 filed by one reporting person, not by a group of insiders.

What type of Repligen (RGEN) securities are involved in this Form 4?

The transaction involves Repligen common stock listed in Table I. Table II for derivative securities does not show any derivative transactions in the provided excerpt.

When was the earliest transaction date reported in this Repligen (RGEN) Form 4?

The earliest transaction date disclosed is 12/17/2025, which matches the date of the sale of 275 shares of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 12/18/2025 - 04:30 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAWES KAREN A

(Last)

(First)

(Middle)

C/O REPLIGEN CORPORATION

41 SEYON ST., BLDG 1, STE 100

(Street)

WALTHAM

02453

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
REPLIGEN CORP [ RGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/17/2025		S		275	D	$161	91,821	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Jennifer Carmichael (Attorney in Fact)	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR